1. Home
  2. MKLY vs GNFT Comparison

MKLY vs GNFT Comparison

Compare MKLY & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKLY
  • GNFT
  • Stock Information
  • Founded
  • MKLY 2025
  • GNFT 1999
  • Country
  • MKLY United States
  • GNFT France
  • Employees
  • MKLY N/A
  • GNFT N/A
  • Industry
  • MKLY
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MKLY
  • GNFT Health Care
  • Exchange
  • MKLY Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • MKLY 237.2M
  • GNFT 216.7M
  • IPO Year
  • MKLY 2025
  • GNFT 2019
  • Fundamental
  • Price
  • MKLY $9.98
  • GNFT $4.44
  • Analyst Decision
  • MKLY
  • GNFT Strong Buy
  • Analyst Count
  • MKLY 0
  • GNFT 2
  • Target Price
  • MKLY N/A
  • GNFT $10.00
  • AVG Volume (30 Days)
  • MKLY 70.6K
  • GNFT 10.0K
  • Earning Date
  • MKLY 01-01-0001
  • GNFT 09-22-2025
  • Dividend Yield
  • MKLY N/A
  • GNFT N/A
  • EPS Growth
  • MKLY N/A
  • GNFT N/A
  • EPS
  • MKLY N/A
  • GNFT N/A
  • Revenue
  • MKLY N/A
  • GNFT $52,994,715.00
  • Revenue This Year
  • MKLY N/A
  • GNFT $3.14
  • Revenue Next Year
  • MKLY N/A
  • GNFT N/A
  • P/E Ratio
  • MKLY N/A
  • GNFT N/A
  • Revenue Growth
  • MKLY N/A
  • GNFT N/A
  • 52 Week Low
  • MKLY $9.85
  • GNFT $2.55
  • 52 Week High
  • MKLY $10.05
  • GNFT $4.75
  • Technical
  • Relative Strength Index (RSI)
  • MKLY N/A
  • GNFT 62.81
  • Support Level
  • MKLY N/A
  • GNFT $4.10
  • Resistance Level
  • MKLY N/A
  • GNFT $4.38
  • Average True Range (ATR)
  • MKLY 0.00
  • GNFT 0.21
  • MACD
  • MKLY 0.00
  • GNFT 0.04
  • Stochastic Oscillator
  • MKLY 0.00
  • GNFT 100.00

About MKLY McKinley Acquisition Corporation Class A Ordinary Shares

McKinley Acquisition Corp is a blank check company.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: